Clock starts tick­ing on Leif Jo­hansson's re­tire­ment from As­traZeneca chair­man role — re­port

Af­ter sev­en event­ful years marked by a takeover bid, a turn­around mis­sion and some po­lit­i­cal tur­moil, As­traZeneca might be part­ing ways with its chair­man, Leif Jo­hans­son.

The British drug­mak­er’s board is be­gin­ning to plan Jo­hann­son’s suc­ces­sion as a cap on his tenure looms, Sky News re­port­ed. Sources said there was no for­mal time­line but some ac­tion from As­traZeneca’s nom­i­na­tion and gov­er­nance com­mit­tee.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER